Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-503-2 | CAS number: 68259-00-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 09Oct2001 to 26Jul2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Methyl 1-methyl-4-[(methylphenylhydrazono)methyl]pyridinium sulphate
- EC Number:
- 269-503-2
- EC Name:
- Methyl 1-methyl-4-[(methylphenylhydrazono)methyl]pyridinium sulphate
- Cas Number:
- 68259-00-7
- Molecular formula:
- C14H16N3.CH3O4S
- IUPAC Name:
- methyl 1-methyl-4-[(methylphenylhydrazono)methyl]pyridinium sulphate
- Test material form:
- solid: particulate/powder
- Details on test material:
- See study reports for batch and purity information
Constituent 1
- Specific details on test material used for the study:
- Sponsor's Identification: MIP Yellow 2982
Batch No. 028400A8AA
Date Received: September 10, 2001
Physical Description: Yellowish-orange powder with chunks
Storage Conditions: Ambient temperature
Method
- Target gene:
- TA98; hisD3052; uvrB; rfa; pKM101
TA100; hisG46; MvrB; rfa; pKM101
TA1535; hisG46; MvrB; rfa
TA1537; hisC3016; uvrB; rfa
WP2MvrA; trp; uvrA;
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Additional strain / cell type characteristics:
- other: TA98; hisD3052; uvrB; rfa; pKM101 TA100; hisG46; MvrB; rfa; pKM101 TA1535; hisG46; MvrB; rfa TA1537; hisC3016; uvrB; rfa WP2MvrA; trp; uvrA;
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 Metabolic Activation System
- Test concentrations with justification for top dose:
- Dose Range finding Assay
A dose range finding study was performed using tester strains TAIOO and WP2MvrA, and ten doses of test article ranging from 6.67 to 5000 ug/plate, in the absence of S9 and in the presence of standard S9 (one plate per dose; Experiment 22733-Al; Tables 1 and 2). Inhibited growth (characterized by a decreased revertant frequency or a thinning of the background lawn) was observed in tester strain TA100 at doses >667 µg/plate with S9 and >100 µg/plate without S9, and in tester strain WP2uvrA at doses >1000 ug/plate with S9 and >667 ug/plate without S9. In addition, the test article was found to be freely soluble, at all doses evaluated with and without S9.
Based upon these results, the test article was evaluated in the initial mutagenicity assay in all five tester strains at doses of 33.3,100, 333, 1000, 3330 and 5000 ug/plate in the presence of S9 (both types), and at doses 33.3,100, 333, 1000, 2000 and 3330 µg/plate in the absence of S9 (Experiment 22733-Bl, Tables 3-5). Inhibited growth was observed in all five tester strains at the highest 2-3 dose levels with S9 (both types), and at the highest 1-4 dose levels without S9. - Vehicle / solvent:
- Water
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 2-nitrofluorene
- sodium azide
- benzo(a)pyrene
- congo red
- other: 2-aminoanthracene; ICR-191;
- Details on test system and experimental conditions:
- Tester Strains. The tester strains used were the Salmonella typhimurium histidine auxotrophs TA98, TAIOO, TAI535 and TA1537 (Ames et al., 1975) and the Escherichia coli tryptophan auxotroph WP2MvrA (Green and Muriel, 1976). The specific genotypes of the strains are shown below
TA98; hisD3052; uvrB; rfa; pKM101
TA100; hisG46; MvrB; rfa; pKM101
TA1535; hisG46; MvrB; rfa
TA1537; hisC3016; uvrB; rfa
WP2MvrA; trp; uvrA;
In addition to a mutation in the histidine or tryptophan operons, the tester strains contain two additional mutations which enhance their sensitivity to some mutagenic compounds. A mutation
Plating Procedures
These procedures were used in the dose rangefinding study and the mutagenicity assays. Each plate was labeled with a code which identified the test article, test phase, tester strain, activation condition and dose level. The S9 mixes and dilutions of the test article were prepared immediately prior to their use.
When S9 mix was required, 500 \xL of the appropriate mix was added to 13 x 100 mm glass culture tubes which had been pre-heated to 30 or 37°C ± 2°C (for reductive and standard S9 mixes, respectively). To these tubes were added 100 jiL of tester strain and 50 \iL of test or control article. If S9 mix was not required, 500 |JL of O.IM phosphate buffer was substituted for the standard S9 mix. After the required components had been added, the mixture was vortexed. Cultures treated with standard S9 or without S9 were incubated for 20 ± 2 minutes at 37 ± 2°C, while those treated with reductive S9 were incubated for 30 ± 2 minutes at 30 ± 2°C.
Following the 20- or 30-minute pre-incubation, 2 mL of molten selective top agar was then added to each tube, and the mixture was vortexed aiid overlaid onto 25 mL of minimal bottom agar contained in a 15 x 100 mm petri dish. After the overlay had solidified, the plates were inverted and incubated for 52 ± 4 hr at 37 ± 2°C. Positive control articles were plated using a 50 ML plating aliquot.
Scoring the Plates
Plates which were not evaluated immediately following the incubation period were held at 5 ± 3°C until such time that colony counting and bacterial background lawn evaluation could take place.
Bacterial Background Lawn Evaluation. The condition of the bacterial background lawn was evaluated macroscopically and microscopically (using a dissecting microscope) for indications of cytotoxicity and test article precipitate (except as noted below; see Protocol Deviation). Evidence of cytotoxicity was scored relative to the vehicle control plate and was recorded along with the revertant counts for all plates at that dose level. Lawns were scored as normal (N), reduced (R), obscured by precipitate (O), macroscopic precipitate present (P), absent (A), or enhanced (E); contaminated plates (C) also were noted.
Counting Revertant Colonies. Revertant colonies were counted by automated colony counter or by hand. - Rationale for test conditions:
- The bacterial reverse mutation assay detects point mutations, both frameshifts and/or base pair substitutions. The strains of Salmonella typhimurium and Escherichia coli used in this assay are histidine and tryptophan auxotrophs, respectively, by virtue of conditionally lethal mutations in the appropriate operons. When these histidine (his-) or tryptophan (trp-) dependant cells, are exposed to the test article and grown under selective conditions (minimal media with a trace amount of histidine or tryptophan) only those cells which revert to histidine (his+) or tryptophan (trp+) independence are able to form colonies. The trace amount of histidine or tryptophan in the media allows all the plated bacteria to undergo a few cell divisions, which is essential for mutagenesis to be fully expressed. The his+ or trp+ revertants are readily discernible as colonies against the limited background growth of the his- or trp- cells. By utilizing several different tester strains, both base pair substitution mutations and frameshift mutations can be detected.
The bacterial reverse mutation assay has been shown to be a sensitive, rapid and accurate
indicator of the mutagenic activity of many materials including a wide range of chemical classes. - Evaluation criteria:
- Assay Evaluation Criteria
Once the criteria for a valid assay had been met, responses observed in the assay were evaluated.
Tester Strains TA98, TA100 and WP2avrA. For a test article to be considered positive, it had to produce at least a 2-fold increase in the mean revertants per plate of at least one of these tester strains over the mean revertants per plate of the appropriate vehicle control. This increase in the mean number of revertants per plate had to be accompanied by a dose response to increasing concentrations of the test article.
Tester Strains TA1535 and TA1537. For a test article to be considered positive, it had to produce at least a 3-fold increase in the mean revertants per plate of at least one of these tester strains over the mean revertants per plate of the appropriate vehicle control. This increase in the mean number of revertants per plate had to be accompanied by a dose response to increasing concentrations of the test article. - Statistics:
- N/A
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- observed during range finding study
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- observed dring range finding study
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
Applicant's summary and conclusion
- Conclusions:
- The results of the Salmonella-Escherichia coli/Mammalian-Microsome Reverse Mutation Assay: Preincubation Method with a Confirmatory Assay indicate that, under the conditions of this study, the test item did not cause a positive increase in revertant frequencies in any tester strain with or without standard or reductive S9.
- Executive summary:
The objective of this study was to evaluate the test article and/or its metabolites for their ability to induce reverse mutations at the histidine locus in several strains of Salmonella typhimurium and at the tryptophan locus of Escherichia coli strain WP2MvrA. Evaluation of the test article was performed in the absence of exogenous metabolic activation, as well as in the presence of standard (Aroclor 1254-TM-induced male Sprague-Dawley rat liver) and reductive (uninduced male Golden Syrian hamster liver with FMN) metabolic activation systems (S9s).
A dose range finding study was performed using tester strains TA100 and WP2MvrA, and ten doses of test article ranging from 6.67 to 5000 µg/plate, in the absence of S9 and in the presence of standard S9 (one plate per dose). Inhibited growth (characterized by a decreased revertant frequency or a thinning of the background lawn) was observed in tester strain TA100 at doses >667 µg/plate with S9 and >100 µg/plate without S9, and in tester strain WP2uvrA at doses >1000 µg/plate with S9 and >667 µg/plate without S9. In addition, the test article was found to be freely soluble, at all doses evaluated with and without S9.
Based upon these results, the test article was evaluated in the initial mutagenicity assay in all five tester strains at doses of 33.3, 100, 333,1000, 3330 and 5000 µg/plate in the presence of S9 (both types) and at doses 33.3, 100, 333,1000, 2000 and 3330 µg/plate in the absence of S9. Inhibited growth was observed in all five tester strains at the highest 2-3 dose levels with S9 (both types), and at the highest 1-4 dose levels without S9. The test article again was found to be freely soluble at all doses evaluated with and without S9. Increases in revertant frequencies, to approximately 2.1- to 3.1-fold control values, were observed in tester strains WP2uvrA and TA1537, respectively, in the presence of reductive S9. However, these increases did not appear to be dose dependent, and those observed in tester strain WP2uvrA were within acceptable vehicle control ranges. Revertant frequencies for all other tester strain/S9 combinations approximated or were less than those observed in the concurrent negative control cultures.
The test article was re-evaluated in an independent confirmatory assay under identical conditions (except that a dose of 2000 µg/plate was added with both S9s). Inhibited growth again was observed in all five tester strains at the highest 2-4 dose levels with and without S9 (both types), and the test article again was found to be freely soluble at all doses evaluated with and without S9. Revertant frequencies for all doses of MIP Yellow 2982, in all tester strain/S9 combinations, approximated negative control values. All positive and negative control values in both assays were within acceptable ranges, and all criteria for a valid study were met.
The results of the Salmonella-Escherichia coli/Mammalian-Microsome Reverse Mutation Assay: Preincubation Method with a Confirmatory Assay indicate that, under the conditions of this study, the test item did not cause a positive increase in revertant frequencies in any tester strain with or without standard or reductive S9.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.